These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 37296967)
1. Current Model Systems for Investigating Epithelioid Haemangioendothelioma. Neil E; Kouskoff V Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296967 [TBL] [Abstract][Full Text] [Related]
2. A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review. Abdelmogod A; Papadopoulos L; Riordan S; Wong M; Weltman M; Lim R; McEvoy C; Fellowes A; Fox S; Bedő J; Penington J; Pham K; Hofmann O; Vissers JHA; Grimmond S; Ratnayake G; Christie M; Mitchell C; Murray WK; McClymont K; Luk P; Papenfuss AT; Kee D; Scott CL; Goldstein D; Barker HE Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686662 [TBL] [Abstract][Full Text] [Related]
3. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex. Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR Elife; 2021 Apr; 10():. PubMed ID: 33913810 [TBL] [Abstract][Full Text] [Related]
7. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms. Anderson WJ; Fletcher CDM; Hornick JL Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063 [TBL] [Abstract][Full Text] [Related]
8. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma. Lamar JM; Motilal Nehru V; Weinberg G Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996478 [TBL] [Abstract][Full Text] [Related]
9. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300 [TBL] [Abstract][Full Text] [Related]
10. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma. Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984 [TBL] [Abstract][Full Text] [Related]
11. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant. Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774 [TBL] [Abstract][Full Text] [Related]
12. Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma. Seavey CN; Pobbati AV; Rubin BP Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740643 [TBL] [Abstract][Full Text] [Related]
13. Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma. Seavey CN; Hallett A; Li S; Che K; Pobbati AV; Ma S; Burtscher A; Kanai R; Lamar JM; Rubin BP Clin Cancer Res; 2023 Jul; 29(13):2480-2493. PubMed ID: 36598859 [TBL] [Abstract][Full Text] [Related]
14. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma. Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence Yang P; Zhang S; Yu C; Yan W; Yang N; Li N; Huang Y; Chen H; Cai Z; Zhao Y; Qin Y; Gong X; Feng Z Am J Transl Res; 2020; 12(8):4561-4568. PubMed ID: 32913529 [TBL] [Abstract][Full Text] [Related]
16. The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription. Neil E; Paredes R; Pooley O; Rubin B; Kouskoff V Commun Biol; 2023 Nov; 6(1):1174. PubMed ID: 37980390 [TBL] [Abstract][Full Text] [Related]